 |
|
|
 |
|
 |
|
| More than 80% of Teikoku Seiyaku products (sales) are used at healthcare organizations.
In addition, we actively engage in joint research and development with other companies,
both in Japan and overseas. Our business model involves combining our expertise in
transdermal absorption technology with the drug development capabilities of other
companies. Upon development, new products are marketed through the sales networks
of our corporate partners. |
|
|
|
|
|
